4-Vinylphenol

4-Vinylphenol

SCHEMBL20584761

C=Cc1ccc(O)cc1.[KH]

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.65
▸ ALDH5A1 P51649 2/20 0.50
▸ ABAT P80404 2/20 0.50
▸ MAPT P10636 5/20 0.48
▸ APP P05067 4/20 0.48
▸ TSHR P16473 1/20 0.48
▸ KDM4E B2RXH2 4/20 0.47
▸ MEN1 O00255 3/20 0.47
▸ CA12 O43570 3/20 0.47
▸ CA1 P00915 3/20 0.47
▸ CA2 P00918 3/20 0.47
▸ LMNA P02545 3/20 0.47
▸ CA3 P07451 3/20 0.47
▸ CYP3A4 P08684 3/20 0.47
▸ HPGD P15428 3/20 0.47
▸ CA4 P22748 3/20 0.47
▸ CA5A P35218 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ HIF1A Q16665 3/20 0.47
▸ CA9 Q16790 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
4-Vinylphenol SCHEMBL170622 0.97 ALDH1A1 (0.69) ALDH1A1ALDH5A1ABATMAPTAPP
4-Vinylphenol SCHEMBL59328 0.97 — —
4-Vinylphenol SCHEMBL10915625 0.94 ALDH1A1 (0.65) ALDH1A1ALDH5A1ABATMAPTAPP
4-Vinylphenol SCHEMBL31482515 0.94 ALDH1A1 (0.65) ALDH1A1ALDH5A1ABATMAPTAPP
4-Vinylphenol SCHEMBL11445443 0.94 ALDH1A1 (0.65) ALDH1A1ALDH5A1ABATMAPTAPP
4-Vinylphenol SCHEMBL17288723 0.94 ALDH1A1 (0.65) ALDH1A1ALDH5A1ABATMAPTAPP
4-Vinylphenol SCHEMBL3839728 0.94 ALDH1A1 (0.65) ALDH1A1ALDH5A1ABATMAPTAPP
4-Vinylphenol SCHEMBL10538331 0.94 ALDH1A1 (0.65) ALDH1A1ALDH5A1ABATMAPTAPP
4-Vinylphenol SCHEMBL30831043 0.94 ALDH1A1 (0.65) ALDH1A1ALDH5A1ABATMAPTAPP
4-Vinylphenol SCHEMBL28477989 0.94 ALDH1A1 (0.65) ALDH1A1ALDH5A1ABATMAPTAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109964540-B Organic EL display device 东丽株式会社 2022-04-01 — — CN disclosed
US-10544080-B2 Continuous process for the conversion of olefins and carbon dioxide to acrylates via solution phase reactor CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2020-01-28 — — US disclosed
CN-106748749-B A method of triisobutylene in separation tert-butyl acrylate reaction solution 万华化学集团股份有限公司 2019-06-18 — — CN disclosed
US-10160711-B2 Formation of α,β-unsaturated carboxylic acids and salts thereof from metalalactones and anionic polyelectrolytes CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2018-12-25 — — US disclosed
US-20180362436-A1 CONTINUOUS PROCESS FOR THE CONVERSION OF OLEFINS AND CARBON DIOXIDE TO ACRYLATES VIA SOLUTION PHASE REACTOR CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2018-12-20 — — US disclosed
CN-106565869-B A kind of solid super-strong acid and its preparation method and application 万华化学集团股份有限公司 2018-08-28 — — CN disclosed
CN-106748749-A A kind of method for separating TIB in tert-butyl acrylate reaction solution 万华化学集团股份有限公司 2017-05-31 — — CN disclosed
CN-106565869-A Solid super acid and preparation method and application thereof 万华化学集团股份有限公司 2017-04-19 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180362436-A1 CONTINUOUS PROCESS FOR THE CONVERSION OF OLEFINS AND CARBON DIOXIDE TO ACRYLATES VIA SOLUTION PHASE REACTOR DEGS1, AP2S1, OSTC ALDH1A1 551/4885ALDH5A1 1582/4885ABAT 1796/4885
US-10160711-B2 Formation of α,β-unsaturated carboxylic acids and salts thereof from metalalactones and anionic polyelectrolytes ALOX12, DEGS1, ALOX15 ALDH1A1 401/4885ALDH5A1 2493/4885ABAT 919/4885
US-10544080-B2 Continuous process for the conversion of olefins and carbon dioxide to acrylates via solution phase reactor DEGS1, AP2S1, OSTC ALDH1A1 551/4885ALDH5A1 1582/4885ABAT 1796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback